BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sharma M, Pruitt K. Wnt Pathway: An Integral Hub for Developmental and Oncogenic Signaling Networks. Int J Mol Sci 2020;21:E8018. [PMID: 33126517 DOI: 10.3390/ijms21218018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Rasha F, Sharma M, Pruitt K. Mechanisms of endocrine therapy resistance in breast cancer. Mol Cell Endocrinol 2021;532:111322. [PMID: 34000350 DOI: 10.1016/j.mce.2021.111322] [Reference Citation Analysis]
2 Emanuele S, Giuliano M. Dual Function Molecules and Processes in Cell Fate Decision: A Preface to the Special Issue. Int J Mol Sci 2020;21:E9601. [PMID: 33339424 DOI: 10.3390/ijms21249601] [Reference Citation Analysis]
3 Khoramjoo SM, Kazemifard N, Baradaran Ghavami S, Farmani M, Shahrokh S, Asadzadeh Aghdaei H, Sherkat G, Zali MR. Overview of Three Proliferation Pathways (Wnt, Notch, and Hippo) in Intestine and Immune System and Their Role in Inflammatory Bowel Diseases (IBDs). Front Med 2022;9:865131. [DOI: 10.3389/fmed.2022.865131] [Reference Citation Analysis]
4 Hoffmann N, Peters J. Functions of the (pro)renin receptor (Atp6ap2) at molecular and system levels: pathological implications in hypertension, renal and brain development, inflammation, and fibrosis. Pharmacol Res 2021;173:105922. [PMID: 34607004 DOI: 10.1016/j.phrs.2021.105922] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Dittmer J. Nuclear Mechanisms Involved in Endocrine Resistance. Front Oncol 2021;11:736597. [PMID: 34604071 DOI: 10.3389/fonc.2021.736597] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Evans JF, Obraztsova K, Lin SM, Krymskaya VP. CrossTORC and WNTegration in Disease: Focus on Lymphangioleiomyomatosis. Int J Mol Sci 2021;22:2233. [PMID: 33668092 DOI: 10.3390/ijms22052233] [Reference Citation Analysis]
7 Kang BW, Chau I. Emerging agents for metastatic pancreatic cancer: spotlight on early phase clinical trials. Expert Opin Investig Drugs 2021;:1-19. [PMID: 34727804 DOI: 10.1080/13543784.2021.1995354] [Reference Citation Analysis]
8 Castilla-Vallmanya L, Gürsoy S, Giray-Bozkaya Ö, Prat-Planas A, Bullich G, Matalonga L, Centeno-Pla M, Rabionet R, Grinberg D, Balcells S, Urreizti R. De Novo PORCN and ZIC2 Mutations in a Highly Consanguineous Family. Int J Mol Sci 2021;22:1549. [PMID: 33557041 DOI: 10.3390/ijms22041549] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Molehin D, Filleur S, Pruitt K. Regulation of aromatase expression: Potential therapeutic insight into breast cancer treatment. Mol Cell Endocrinol 2021;531:111321. [PMID: 33992735 DOI: 10.1016/j.mce.2021.111321] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Sniegowski T, Korac K, Bhutia YD, Ganapathy V. SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine-Glycine-One-Carbon Pathways in Cancer. Pharmaceuticals (Basel) 2021;14:216. [PMID: 33806675 DOI: 10.3390/ph14030216] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Sharma M, Castro-Piedras I, Rodgers AD, Pruitt K. Genomic profiling of DVL-1 and its nuclear role as a transcriptional regulator in triple negative breast cancer. Genes Cancer 2021;12:77-95. [PMID: 34659647 DOI: 10.18632/genesandcancer.217] [Reference Citation Analysis]
12 He J, Ling L, Liu Z, Ren X, Wan L, Tu C, Li Z. Functional interplay between long non-coding RNAs and the Wnt signaling cascade in osteosarcoma. Cancer Cell Int 2021;21:313. [PMID: 34130697 DOI: 10.1186/s12935-021-02013-8] [Reference Citation Analysis]
13 Wu K, Zhai X, Huang S, Jiang L, Yu Z, Huang J. Protein Kinases: Potential Drug Targets Against Schistosoma japonicum. Front Cell Infect Microbiol 2021;11:691757. [PMID: 34277472 DOI: 10.3389/fcimb.2021.691757] [Reference Citation Analysis]
14 Castro-Piedras I, Sharma M, Brelsfoard J, Vartak D, Martinez EG, Rivera C, Molehin D, Bright RK, Fokar M, Guindon J, Pruitt K. Nuclear Dishevelled targets gene regulatory regions and promotes tumor growth. EMBO Rep 2021;22:e50600. [PMID: 33860601 DOI: 10.15252/embr.202050600] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Muccioli S, Brillo V, Chieregato L, Leanza L, Checchetto V, Costa R. From Channels to Canonical Wnt Signaling: A Pathological Perspective. Int J Mol Sci 2021;22:4613. [PMID: 33924772 DOI: 10.3390/ijms22094613] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Sharma M, Castro-Piedras I, Rasha F, Ramachandran S, Sennoune SR, Furr K, Almodovar S, Ganapathy V, Grisham MB, Rahman RL, Pruitt K. Dishevelled-1 DIX and PDZ domain lysine residues regulate oncogenic Wnt signaling. Oncotarget 2021;12:2234-51. [PMID: 34733415 DOI: 10.18632/oncotarget.28089] [Reference Citation Analysis]
17 Yu M, Yang Y, Sykes M, Wang S. Small-Molecule Inhibitors of Tankyrases as Prospective Therapeutics for Cancer. J Med Chem 2022. [PMID: 35306814 DOI: 10.1021/acs.jmedchem.1c02139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]